{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:34:00Z","timestamp":1768444440524,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bbi.2017.08.016","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T20:33:03Z","timestamp":1503606783000},"page":"152-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-\u03b1-induced depression model"],"prefix":"10.1016","volume":"67","author":[{"given":"Charlotte K.","family":"Callaghan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Rouine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reginald L.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian I.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Bidlack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Deaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane M.","family":"O'Mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2017.08.016_b0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/1098-1063(2000)10:4<466::AID-HIPO13>3.0.CO;2-Y","article-title":"Identifying cortical inputs to the rat hippocampus that subserve allocentric spatial processes: a simple problem with a complex answer","volume":"10","author":"Aggleton","year":"2000","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbi.2017.08.016_b0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1440-1746.2011.07035.x","article-title":"Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection","volume":"27","author":"Alavi","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbi.2017.08.016_b0015","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1073\/pnas.92.11.5062","article-title":"The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids","volume":"92","author":"Arvidsson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2017.08.016_b0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.vascn.2008.12.002","article-title":"Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse","volume":"59","author":"Balu","year":"2009","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bbi.2017.08.016_b0025","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1523\/JNEUROSCI.5289-06.2007","article-title":"Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex","volume":"27","author":"Barker","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.08.016_b0030","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","article-title":"Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2017.08.016_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02246283","article-title":"Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats","volume":"123","author":"Besson","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2017.08.016_b0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0091-3057(98)00002-1","article-title":"Reversal of learned helplessness by morphine in rats: involvement of a dopamine mediation","volume":"60","author":"Besson","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2017.08.016_b0045","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.peptides.2010.09.016","article-title":"Endogenous opiates and behavior: 2009","volume":"31","author":"Bodnar","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.bbi.2017.08.016_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2017.08.016_b0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fncel.2014.00430","article-title":"Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity","volume":"8","author":"Calabrese","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2017.08.016_b0060","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hipo.22033","article-title":"Differential BDNF signaling in dentate gyrus and perirhinal cortex during consolidation of recognition memory in the rat","volume":"22","author":"Callaghan","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbi.2017.08.016_b0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nlm.2013.04.011","article-title":"Neurotrophins play differential roles in short and long-term recognition memory","volume":"104","author":"Callaghan","year":"2013","journal-title":"Neurobiol. Learn Memory"},{"key":"10.1016\/j.bbi.2017.08.016_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2017.07.018","article-title":"Exercise prevents IFN-alpha-induced mood and cognitive dysfunction and increases BDNF expression in the rat","author":"Callaghan","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2017.08.016_b0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopsych.2005.03.033","article-title":"Anterior cingulate activation and error processing during interferon-alpha treatment","volume":"58","author":"Capuron","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","article-title":"Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and\/or interferon-alpha cancer therapy","volume":"18","author":"Capuron","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2017.08.016_b0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2017.08.016_b0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0306-4522(93)90238-B","article-title":"Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum","volume":"54","author":"Chen","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2017.08.016_b0095","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbi.2017.08.016_b0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nlm.2007.02.001","article-title":"Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice","volume":"88","author":"Daumas","year":"2007","journal-title":"Neurobiol. Learn Memory"},{"key":"10.1016\/j.bbi.2017.08.016_b0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2015.05.015","article-title":"Acute changes in striatal microstructure predict the development of interferon-alpha induced fatigue","volume":"79","author":"Dowell","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ijcp.12268","article-title":"Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis","volume":"68","author":"Ehret","year":"2014","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bbi.2017.08.016_b0120","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/PL00005603","article-title":"Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix","volume":"113","author":"Ennaceur","year":"1997","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbi.2017.08.016_b0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.physbeh.2008.05.008","article-title":"Interferon-alpha-induced deficits in novel object recognition are rescued by chronic exercise","volume":"95","author":"Fahey","year":"2008","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2017.08.016_b0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbr.2007.05.005","article-title":"The widely-used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats","volume":"182","author":"Fahey","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2017.08.016_b0135","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","article-title":"Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression","volume":"62","author":"Felger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.physbeh.2015.12.013","article-title":"Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus","volume":"166","author":"Felger","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2017.08.016_b0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbi.2017.08.016_b0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-5793(93)81011-N","article-title":"Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes","volume":"327","author":"Fukuda","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbi.2017.08.016_b0155","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.mp.4002055","article-title":"Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression","volume":"13","author":"Goshen","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/nedt.2006.2.3.355","article-title":"Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments","volume":"2","author":"Gupta","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2017.08.016_b0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1124\/jpet.300.1.213","article-title":"Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland","volume":"300","author":"Houghtling","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2017.08.016_b0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2017.08.016_b0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0006-8993(87)91604-0","article-title":"Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides","volume":"435","author":"Iyengar","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2017.08.016_b0180","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hipo.20330","article-title":"Cingulate cortex projections to the parahippocampal region and hippocampal formation in the rat","volume":"17","author":"Jones","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbi.2017.08.016_b0185","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/sj.npp.1301137","article-title":"Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus","volume":"31","author":"Kaneko","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2017.08.016_b0190","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archpsyc.63.11.1199","article-title":"Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women","volume":"63","author":"Kennedy","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314","author":"Knoll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2017.08.016_b0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clpt.2004.09.007","article-title":"Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin","volume":"77","author":"Kraus","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2017.08.016_b0205","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/npp.2013.1","article-title":"Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the delta opioid receptor","volume":"38","author":"Le Merrer","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2017.08.016_b0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbi.2016.04.005","article-title":"Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus","volume":"56","author":"Lebonville","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2017.08.016_b0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eurpsy.2004.09.030","article-title":"Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study","volume":"21","author":"Lieb","year":"2006","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbi.2017.08.016_b0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbi.2017.08.016_b0230","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2017.08.016_b0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2017.08.016_b0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s002130050031","article-title":"Human interferon-alpha increases immobility in the forced swimming test in rats","volume":"148","author":"Makino","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2017.08.016_b0245","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J. Compar. Neurol."},{"key":"10.1016\/j.bbi.2017.08.016_b0250","first-page":"2445","article-title":"Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain","volume":"7","author":"Mansour","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.08.016_b0255","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1523\/JNEUROSCI.5569-03.2004","article-title":"Role of hippocampal CA3 mu-opioid receptors in spatial learning and memory","volume":"24","author":"Meilandt","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.08.016_b0260","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1073\/pnas.90.21.9954","article-title":"Cloning and pharmacological characterization of a rat kappa opioid receptor","volume":"90","author":"Meng","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2017.08.016_b0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jad.2016.08.029","article-title":"Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants","volume":"208","author":"Mischoulon","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2017.08.016_b0270","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1088417","article-title":"Inflammatory blockade restores adult hippocampal neurogenesis","volume":"302","author":"Monje","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbi.2017.08.016_b0275","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1085\/jgp.107.6.663","article-title":"The hippocampus as a cognitive graph","volume":"107","author":"Muller","year":"1996","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bbi.2017.08.016_b0280","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00239813","article-title":"Hippocampal place units in the freely moving rat: why they fire where they fire","volume":"31","author":"O'Keefe","year":"1978","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbi.2017.08.016_b0285","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1212\/WNL.45.5.947","article-title":"Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia","volume":"45","author":"Pavol","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2017.08.016_b0290","first-page":"516","article-title":"Depressive disorders and symptoms accompanying pegylated interferon alpha and ribavirin treatment of chronic hepatitis C patients","volume":"24","author":"Pawelczyk","year":"2008","journal-title":"Pol Merkur Lekarski"},{"key":"10.1016\/j.bbi.2017.08.016_b0295","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(94)90294-1","article-title":"Reversible cognitive decline during high-dose alpha-interferon treatment","volume":"47","author":"Poutiainen","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2017.08.016_b0300","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbi.2009.07.001","article-title":"Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality","volume":"23","author":"Prather","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2017.08.016_b0305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mp.2015.110","article-title":"Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction","volume":"21","author":"Prossin","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2017.08.016_b0310","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1471-4906(03)00003-6","article-title":"Opioid G protein-coupled receptors: signals at the crossroads of inflammation","volume":"24","author":"Rogers","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2017.08.016_b0315","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0306-4522(97)00605-2","article-title":"Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect","volume":"85","author":"Sandin","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2017.08.016_b0320","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1073\/pnas.91.10.4219","article-title":"Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue","volume":"91","author":"Schafer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2017.08.016_b0325","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/jnp.16.2.185","article-title":"Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy","volume":"16","author":"Scheibel","year":"2004","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2017.08.016_b0330","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbi.2017.08.016_b0335","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0028-3908(87)90084-0","article-title":"Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro","volume":"26","author":"Smith","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2017.08.016_b0340","doi-asserted-by":"crossref","first-page":"20615","DOI":"10.1074\/jbc.M114.568659","article-title":"Rapamycin and interleukin-1beta impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy","volume":"289","author":"Smith","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2017.08.016_b0345","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/CRIAI:28:3:249","article-title":"Role of IL-6 in the neural stem cell differentiation","volume":"28","author":"Taga","year":"2005","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bbi.2017.08.016_b0350","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1073\/pnas.84.12.4308","article-title":"Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography","volume":"84","author":"Tempel","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2017.08.016_b0355","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.neurobiolaging.2007.02.027","article-title":"Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction","volume":"29","author":"Tong","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2017.08.016_b0360","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbi.2017.08.016_b0365","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.psyneuen.2013.03.007","article-title":"Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms","volume":"38","author":"Udina","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2017.08.016_b0370","first-page":"39","article-title":"Mood and cognitive side effects of interferon-alpha therapy","volume":"25","author":"Valentine","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbi.2017.08.016_b0375","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bmcl.2008.10.134","article-title":"Syntheses and opioid receptor binding properties of carboxamido-substituted opioids","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbi.2017.08.016_b0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3565(24)35275-9","article-title":"Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice","volume":"292","author":"Yamano","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911730404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911730404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:47:02Z","timestamp":1760168822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915911730404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":76,"alternative-id":["S088915911730404X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.08.016","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-\u03b1-induced depression model","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}